GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Cyclically Adjusted PB Ratio

Anterogen Co (XKRX:065660) Cyclically Adjusted PB Ratio : 2.35 (As of Jun. 04, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Anterogen Co's current share price is ₩22600.00. Anterogen Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₩9,617.56. Anterogen Co's Cyclically Adjusted PB Ratio for today is 2.35.

The historical rank and industry rank for Anterogen Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:065660' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.52   Med: 2.01   Max: 2.49
Current: 2.37

During the past years, Anterogen Co's highest Cyclically Adjusted PB Ratio was 2.49. The lowest was 1.52. And the median was 2.01.

XKRX:065660's Cyclically Adjusted PB Ratio is ranked worse than
62.02% of 674 companies
in the Biotechnology industry
Industry Median: 1.475 vs XKRX:065660: 2.37

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Anterogen Co's adjusted book value per share data for the three months ended in Mar. 2025 was ₩9,424.009. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩9,617.56 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Anterogen Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Anterogen Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Cyclically Adjusted PB Ratio Chart

Anterogen Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.99

Anterogen Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.56 1.99 1.96

Competitive Comparison of Anterogen Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Anterogen Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anterogen Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anterogen Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Anterogen Co's Cyclically Adjusted PB Ratio falls into.


;
;

Anterogen Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Anterogen Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=22600.00/9617.56
=2.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anterogen Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Anterogen Co's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=9424.009/122.5900*122.5900
=9,424.009

Current CPI (Mar. 2025) = 122.5900.

Anterogen Co Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 100.051 0.000
201509 0.000 100.111 0.000
201512 2,468.008 100.220 3,018.877
201603 4,625.204 100.561 5,638.412
201606 4,580.334 100.791 5,570.982
201609 4,610.845 101.461 5,571.031
201612 4,559.002 101.561 5,502.963
201703 4,659.507 102.851 5,553.774
201706 5,705.959 102.611 6,816.925
201709 5,860.592 103.491 6,942.183
201712 5,859.483 102.991 6,974.546
201803 6,071.335 104.101 7,149.656
201806 6,154.539 104.130 7,245.585
201809 5,974.255 105.651 6,932.139
201812 6,643.688 104.351 7,804.928
201903 7,817.058 104.491 9,171.068
201906 7,452.319 104.881 8,710.640
201909 6,764.712 105.200 7,882.925
201912 7,889.084 105.121 9,200.065
202003 7,666.911 105.354 8,921.207
202006 8,225.637 105.112 9,593.412
202009 8,133.787 106.198 9,389.298
202012 8,914.346 105.765 10,332.393
202103 9,767.988 107.357 11,153.958
202106 10,874.494 107.579 12,391.909
202109 11,534.630 108.759 13,001.477
202112 12,403.587 109.676 13,864.019
202203 13,896.316 111.848 15,230.933
202206 11,762.537 114.072 12,640.838
202209 11,240.226 114.715 12,011.818
202212 10,974.348 115.179 11,680.454
202303 11,400.091 116.507 11,995.265
202306 12,052.811 117.182 12,609.043
202309 14,124.906 118.964 14,555.479
202312 13,302.326 118.837 13,722.416
202403 11,785.842 120.123 12,027.871
202406 11,791.863 120.007 12,045.638
202409 11,561.962 120.861 11,727.344
202412 11,325.826 121.135 11,461.846
202503 9,424.009 122.590 9,424.009

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Anterogen Co  (XKRX:065660) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Anterogen Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Anterogen Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Anterogen Co Business Description

Traded in Other Exchanges
N/A
Address
Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589
Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co Headlines

No Headlines